Skip to main content

RHUMBLINE ADVISERS

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1115418 BOSTON, MA

Position in NTLA

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2,990,187
+$1,239,129 QoQ
Shares Held
176,725
+29.4% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 330 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 17% Shared 0% None 83%

Common Shares in NTLA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. NTLA ranks #75 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NTLA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,990,187 176,725
2026-03-31 $1,751,058 136,588
2025-12-31 $1,190,860 132,465
2025-09-30 $2,754,202 159,479
2025-06-30 $1,540,627 164,246
2025-03-31 $1,115,118 156,838
2024-12-31 $1,938,451 166,248
2024-09-30 $3,344,491 162,749
2024-06-30 $3,923,997 175,335
2024-03-31 $4,581,460 166,538
2023-12-31 $4,980,785 163,358
2023-09-30 $5,185,205 163,985
2023-06-30 $6,622,957 162,407
2023-03-31 $5,508,915 147,811
2022-12-31 $5,033,859 144,278
2022-09-30 $7,153,366 127,830
2022-06-30 $6,188,425 119,560
2022-03-31 $7,139,609 98,247
2021-12-31 $11,306,936 95,627
2021-09-30 $13,251,605 98,782
2021-06-30 $15,942,791 98,467
2021-03-31 $7,786,420 97,021
2020-12-31 $5,550,758 102,036
2020-09-30 $1,946,788 97,927
2020-06-30 $1,928,353 91,739
2020-03-31 $924,979 75,632